Crizotinib. ALK/Met inhibitor, oncolytic

T. Nwizu, R. Kanteti, I. Kawada, C. Rolle, E. E. Vokes, R. Salgia

Research output: Contribution to journalReview articlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Crizotinib. ALK/Met inhibitor, oncolytic'. Together they form a unique fingerprint.

Medicine & Life Sciences